Related Experiment Video
Updated: May 24, 2026

Isolation and Chemical Characterization of Lipid A from Gram-negative Bacteria
Published on: September 16, 2013
MARCKS as a negative regulator of lipopolysaccharide signaling
Mateja Mancek-Keber1, Mojca Bencina, Bostjan Japelj
1Department of Biotechnology, National Institute of Chemistry, Ljubljana 1000, Slovenia.
Abstract:
Myristoylated alanine-rich C kinase substrate (MARCKS) is an intrinsically unfolded protein with a conserved cationic effector domain, which mediates the cross-talk between several signal transduction pathways. Transcription of MARCKS is increased by stimulation with bacterial LPS. We determined that MARCKS and MARCKS-related protein specifically bind to LPS and that the addition of the MARCKS effector peptide inhibited LPS-induced production of TNF-α in mononuclear cells. The LPS binding site within the effector domain of MARCKS was narrowed down to a heptapeptide that binds to LPS in an extended conformation as determined by nuclear magnetic resonance spectroscopy. After LPS stimulation, MARCKS moved from the plasma membrane to FYVE-positive endosomes, where it colocalized with LPS. MARCKS-deficient mouse embryonic fibroblasts (MEFs) responded to LPS with increased IL-6 production compared with the matched wild-type MEFs. Similarly, small interfering RNA knockdown of MARCKS also increased LPS signaling, whereas overexpression of MARCKS inhibited LPS signaling. TLR4 signaling was enhanced by the ablation of MARCKS, which had no effect on stimulation by TLR2, TLR3, and TLR5 agonists. These findings demonstrate that MARCKS contributes to the negative regulation of the cellular response to LPS.
Insights
Myristoylated alanine-rich C kinase substrate (MARCKS) protein binds to bacterial lipopolysaccharide (LPS). MARCKS negatively regulates cellular responses to LPS, impacting inflammatory signaling pathways.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Myristoylated alanine-rich C kinase substrate (MARCKS) is an intrinsically unfolded protein involved in signal transduction.
- MARCKS expression is upregulated by bacterial lipopolysaccharide (LPS), a key immune stimulus.
Purpose of the Study:
- To investigate the role of MARCKS in cellular responses to LPS.
- To elucidate the molecular mechanisms underlying MARCKS-LPS interaction and its functional consequences.
Main Methods:
- Bacterial LPS binding assays with MARCKS and MARCKS-related protein.
- Nuclear magnetic resonance (NMR) spectroscopy to determine LPS binding site.
- Cellular assays using MARCKS-deficient mouse embryonic fibroblasts (MEFs) and small interfering RNA (siRNA) knockdown.
- Analysis of cytokine production (TNF-α, IL-6) and Toll-like receptor (TLR) signaling.
Main Results:
- MARCKS and MARCKS-related protein directly bind to LPS.
- A specific heptapeptide within MARCKS binds LPS in an extended conformation.
- MARCKS translocates to endosomes upon LPS stimulation and colocalizes with LPS.
- MARCKS deficiency or knockdown enhances LPS-induced IL-6 production and TLR4 signaling.
- MARCKS overexpression inhibits LPS signaling, while ablation enhances TLR4 but not TLR2, TLR3, or TLR5 signaling.
Conclusions:
- MARCKS acts as a negative regulator of the cellular response to LPS.
- MARCKS-LPS interaction modulates inflammatory signaling, particularly via TLR4.
- Understanding MARCKS function provides insights into immune regulation and potential therapeutic targets.
Related Concept Videos
Formation of Lipopolysaccharides
Regulation of Bacterial Virulence
Global Regulatory Systems
Inducible Operons: lac Operon
The JAK-STAT Signaling Pathway
Stringent Response in E. coli
